2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¼¼´ëº° ¼öÀÔÂ÷ ºê·£µå ¼±È£ Â÷ÀÌ ¾ç±ØÈ­ (2021-12-29)
KT, ¡®GiGA secure º¸¾È°üÁ¦¡¯ È®´ë (2018-03-12)
Çö´ëÂ÷, »ó¿ë ºÎ¹® ¼ö¼Ò À¥»çÀÌÆ® ¿ÀÇ (2021-04-24)
ÁÖ½Äȸ»ç »ó»ó, ±×·¡ÇÉÆú¸®¸Ó Àû¿ë ¾È°æÅ× °³¹ß (2020-05-12)
±è¼Ò¿¬, ¼¼»ó ´Ù °¡Áø µíÇÑ »ýÀÏ (2015-11-03)
³ó¾÷ȸ»ç¹ýÀÎ ³»¹ä, ±èÀå¿ë °­È­»õ¿ìÁ£ ÆÇ¸Å (2021-10-22)
¹ö·ÁÁú ģȯ°æ ä¼Ò ¿ä¸® ¼Ö·ç¼Ç (2022-10-04)
Alkegen Launching Trio of New High Efficiency Filtration Pro... (2022-10-04)
³ÝÇ÷º½º, ¹Ý·Áµ¿¹° ÁøÁ¤ÇÑ Á¤ÁÖÇà ¦²á µî±Ø (2018-04-11)
¿À¶Ñ±â, ÃÊ°è ¸·±¹¼ö 2Á¾ Ãâ½Ã (2023-06-25)
Á÷ÀåÀÎ 68.4% ³²Àº ¿¬Â÷ ¼ÒÁø ¸øÇØ (2018-10-09)
½ºÆäÀÎ µ¶°¨ÀÇ Áø½Ç¿¡ °üÇÑ Ãæ°ÝÀûÀÎ º¸°í¼­ (2020-09-02)
»ê¾÷ºÎ, ¼³ ¿¬ÈÞ ¾Õ¼­ Àü±â¡¤°¡½º½Ã¼³ ¾ÈÀüÁ¡°Ë ½Ç½Ã (2018-02-02)
SM ÁüÄ«³ª 縰Áö on ½´ÆÛ¹èƲ½ºÅ×ÀÌÁö (2021-11-06)
LG»ýȰ°Ç°­, ¼³ È­Àåǰ ¹× »ýȰ¿ëǰ ¼±¹° ¼¼Æ®(3) (2023-01-10)
È­¼º½Ã¹ÎÀÌ ¾²°í µµ¼­°üÀÌ ´ã´Ù (2021-05-24)
Çö´ëÂ÷, ¡®·Õ±â½ºÆ®·± 2022¡¯ Ä·ÆäÀÎ (2022-10-19)
·ÕÄÚºñµå ȯÀÚ Ä¡·á À§ÇÑ ÀÓ»ó °¡À̵å¶óÀÎ ºÎÁ· (2022-10-19)
·Ôµ¥Á¦°ú, ÆÄŰ½ºÅº ¶ó¸é ½ÃÀå ÁøÃâ (2016-12-14)
Çѱ¹º­¶ô¸í»óÇÐ (2022-05-06)
µÎ³¢, ¿£µ¥¹Í ±â´ë°¨¿¡ â¾÷ ¹®ÀÇ 47% Áõ°¡ (2022-05-06)
¿­¾ÆÈ©, ³» ÀλýÀÇ ½ºÇÁ¸µÄ·ÇÁ (2017-12-11)
¹è¿ì ¡®¼ÛÁ߱⡯ ĭŸŸ ÄÜÆ®¶óº£À̽º ¸ðµ¨ ¼±Á¤ (2023-04-18)
¼­¿ï½Ã, Çϼöó¸® ÀáÀç¿­·Î 1¸¸ 5õ °¡±¸ Áö¿ª³­¹æ (2015-06-12)
¾î´À À§´ëÇÑ ¿¹¼ú°¡ÀÇ Ãß¾ï (2023-01-25)
       [ÀÌÀü][1]....[2296][2297][2298][2299][2300][2301][2302][2303][2304]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..